Articles On Avita Medical (ASX:AVH)

It was a disappointing day for the Avita Medical Inc (ASX: AVH) share price as it hit a new 2-year low. The regenerative medicine company has failed to regain momentum since the beginning of its fall from grace during the COVID-19 crash....

The ASX closed down again today in spite of resources and tech gaining over 1%. The ASX 200 fell 0.24%, closing at 7,434 points. Despite the gains in resources and tech most other sectors fell with financials, property and energy retreating...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has dropped back into the red. At the time of writing, the benchmark index is down 0.15% to 7,442.1 points. Four ASX shares that are falling more than most today are listed below. He...

The Avita Medical Inc (ASX: AVH) share price is sliding well into the red in afternoon trading and is now down 10.98% at $4.54. It comes following the release of the company’s earnings report for the three months ended 30 September 2021....

AVITA Medical (AVH) raked in $7 million in revenue during the first quarter, representing a 39 per cent increase year-on-year The healthcare stock released its quarterly results on Tuesday, revealing its gross profit margin increased from...

The ASX 200 Health Index (XHJ) is up by 0.57% at the time of writing, compared to the broader index which is up by 0.03%. The US FDA has cleared Pharmaxis (ASX:PXS)’s Investigational New Drug application (IND) for a trial of its lead drug,...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these...

Today was a great day on the ASX for the Avita Medical Inc (ASX: AVH) share price. The medical technology company’s stock was boosted by news that the US authority Centers for Medicare and Medicaid Services has approved Avita’s application...

The ASX rose 0.48% today to reach its highest point in the week. While energy lost 2% most other sectors were in the green with tech and financials gaining over 1%. Today’s gains came despite the Federal Reserve unveiling a tapering of stim...

The AVITA Medical Inc (ASX: AVH) share price will be keenly watched when the ASX opens on Thursday after some big news overnight pushed its US shares up 7%. The company provides regenerative medical technology, with its ReCell spray-on ski...

ASX-listed mobile health (mHealth) company Advanced Human Imaging (AHI) is moving forward with its planned dual-listing on the NASDAQ exchange Listing on the NASDAQ will place Advanced Human Imaging on one of the highest-quality and highes...

The AVITA Medical Inc (ASX: AVH) share price is climbing higher this morning following the release of the company’s financial year 2021 (FY21) earnings. at the time of writing, the AVITA share price is up 7.13%, trading at $5.335. AVITA Me...

Highlights AVITA Medical disclosed that the US Food and Drug Administration (FDA) has authorised its request to amend the RECELL® System pivotal trial. Pharmaxis has granted Aptar Pharma an exclusive 12-month option for developing and...

The Avita Medical Inc (ASX: AVH) share price is in the green in early afternoon trade. Avita shares are on the move after the company gained regulatory momentum overnight. Let’s discuss further. A quick refresher on Avita Medical Avita...

Melbourne-based medtech company Avita Medical (ASX: AVH) has received US Food and Drug Administration (FDA) approval to amend its clinical trial for the treatment of vitiligo patients, giving hope to the millions that suffer from the rare s...

Global markets stay cool US stocks edged higher overnight to post their fifth straight day of gains, as attention centred around geo-political concerns following the US withdrawal from Afghanistan. The Dow Jones rose by 0.31%, and the S&am...

In Short & Caught, Stockhead recaps the ASX stocks that are the most shorted right now.   How does shorting work? Shorting works by selling stocks you do not actually own in the hope of buying them back at a lower price. Investors are i...

Buy ASX shares for the long term, we’re always told. Don’t try to time the market. But the irony is the same experts that espouse this to retail investors don’t, or can’t, follow it themselves. That’s because fund managers are judged by po...

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, The Montgomery Fund portfolio manager Joseph Kim reveals a pair of ASX shares that he’d be intrig...

Whether you take a contrarian view to investing or like to hop on what’s hot, it’s interesting to see which ASX sectors have fared the best in the past year. Perhaps you want to put some money into the sectors that haven’t gone so well, th...

One much-hyped ASX share has given little joy to investors over the last 12 months. But The Montgomery Fund portfolio manager Joseph Kim has told holders of the healthcare stock to be patient, as the numbers still look pretty good. Regener...

Wall Street takes record highs even higher All three US benchmarks rose overnight, as American consumer confidence for April rose the highest since the pandemic began and US house prices jumping the most in three decades. The Dow Jones and...

If you are a longer-term shareholder of Avita Medical (ASX:AVH), it is likely you would have experienced a rather disappointing journey over the past 12 months. COVID-19 and lockdowns in the US have stymied the RECELL roll-out just as it wa...

Over the past month, a number of US FDA approvals have moved the share prices of global pharma stocks, including those traded here on the ASX. The biggest FDA announcement during the month came out of US-based Biogen, which received a contr...

While small cap ASX share carry more risk than their larger rivals, the potential returns on offer makes it worth considering including one or two in a balanced portfolio if your risk profile allows. But which small cap shares should you b...

ShareCafeThe Week that Was – June 14-18, 2021 We at ShareCafe understand you are busy and may not have been left with enough time to keep up with the quality content we’ve been bringing you throughout the week. To make it easier to do so, h...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

The S&P/ASX 200 (ASX: XJO) finished at another record, adding 0.1% on Wednesday despite weakening throughout the day. Most sectors finished higher, led by the energy sector, up 1.5%, with the materials and IT down 1.6% and 0.4%, respect...

ShareCafeAvita Medical Gives Shareholders a Lift Investors loved yesterday’s June quarter update from dual-listed skin repair biotech Avita Medical . The company raised its quarterly guidance due to the strength of orders for its flagship t...

Summary Commonwealth Bank (ASX:CBA) sets new high, adds nearly A$7 billion in value over 3 weeks Orthocell (ASX:OCC) gets patents for suture-less repair of soft tissue AF Legal Group (ASX:AFL) completes Watts McCray acquisition...

The S&P/ASX 200 Index (ASX: XJO) rose 0.1% to 7,386 points. Here are some of the highlights from the ASX today: AVITA Medical Inc (ASX: AVH) The Avita share price went up over 12% in reaction to an update about its FY21 fourth quarte...

The ASX climbed briefly past 7,400 points in intra-day trade but ultimately closed just short of the milestone at 7,.368, which was 0.09 per cent higher than yesterday. However, the ASX Emerging Companies Index fell by over 1 per cent for t...

Summary The ASX 200 traded higher in the opening trade even as the US shares ended lower overnight. By 10:30 AM (AEST), the benchmark was trading at 7,391.50, up 0.16%. The US investors awaited the Federal Reserve’s monetary policy st...

The AVITA Medical Inc (ASX: AVH) share price is soaring today, up 9%, after upgrading its FY21 fourth quarter expectations. AVITA is a regenerative medicine company that is developing and commercialising a technology platform that enables p...

The AVITA Medical Inc (ASX: AVH) share price is on the move on Wednesday. At the time of writing, the regenerative medicine company’s shares are up 8% to $5.40. Why is the AVITA share price jumping? Investors have been buying the company’s...

Wall Street nervous as Fed goes into a two-day policy meeting All major indices in the US fell on Tuesday, ahead of a key policy announcement from the US central bank this Thursday (US time). The Dow Jones fell by 0.27%, S&P 500 by 0.20...

Summary Neuroprotective drug developer Argenica Therapeutics commenced trading on the ASX after a well-supported AU$7 million capital raising. The Company disclosed that the ASX listing would allow it to develop its novel neuroprotecti...

The ASX ended the week on a high note, finishing up 0.13 per cent with most sectors in positive territory. The index touched a record high of 7,334 today but failed to keep the momentum and eventually closed at 7,312. For the week, the inde...

Avita Medical Inc. (ASX: AVH) has received a big shot in the arm following an extension of US Food and Drug Administration approvals for the company's treatment of acute burns wounds. The medtech company, which is also listed in the US (N...

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to finish the week on a positive note. In afternoon trade, the benchmark index is up 0.2% to 7,315.8 points. Four ASX shares that are climbing more than most today are listed below. Her...

The Avita Medical Inc (ASX: AVH) share price is flying high on Friday. At the time of writing, shares in the medical technology business are swapping hands for $5.11 – up 13.56%. This comes after the company announced it had received appro...

Burns treatment company Avita Medical (ASX:AVH) rose this morning after gaining further regulatory approval from the FDA. The company has a rapid cell harvesting device called RECELL which works as a ‘spray-on’ and allows patients to be tre...

The AVITA Medical Inc (ASX: AVH) share price is up more than 14% after getting some positive news from the US FDA. AVITA is a regenerative medicine business that is developing and commercialising a “technology platform” that enables point-o...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Wall Street rises despite strong US inflation data All major indices in the US closed higher on Thursday, even as US May consumer prices data rose more than forecast. Headline US CPI rose by 5% on a year-on-year basis for May. Investors are...

The S&P/ASX 200 Index (ASX: XJO) rose by 0.45% today to 7,014 points.  Here are some of the highlights from the ASX: AVITA Medical Inc (ASX: AVH) The AVITA share price went around 3% today after the healthcare business gave its quart...

This morning, medical device developer Avita Medical Inc (ASX: AVH) released its Q3 FY21 results to the market. Avita’s shares are up 2.9% at the time of writing. While many ASX companies saw a V-shaped recovery coming out of COVID-19, Avit...

The AVITA Medical Inc (ASX: AVH) share price is on the move on Friday morning. At the time of writing, the regenerative medicine company’s shares are up 4% to $5.35. Why is the AVITA share price charging higher? Investors have been buying...

Wall Street climbs on better US jobs market All major indices in the US rebounded on Thursday, after US jobless claims fell by 34,000 to a 14-month low of 473,000 in the past week, beating estimates. Dow Jones climbed 1.29%, S&P 500 ros...